id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-P-3630-0006,FDA,FDA-2026-P-3630,Completeness Assessment Correspondence,Other,Assessment Document or Analysis,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T15:19:06Z,,0,0,09000064b92d613f
FDA-2026-P-3630-0005,FDA,FDA-2026-P-3630,"Amendment to Suitability Petition from Rising Pharma Holdings, Inc.",Other,Amendment,2026-04-28T04:00:00Z,2026,4,2026-04-28T04:00:00Z,,2026-04-28T23:36:43Z,,0,0,09000064b92b3d60
FDA-2026-P-3630-0003,FDA,FDA-2026-P-3630,Attachment 1,Supporting & Related Material,Background Material,2026-04-02T04:00:00Z,2026,4,,,2026-04-02T23:42:21Z,,0,0,09000064b924c861
FDA-2026-P-3630-0004,FDA,FDA-2026-P-3630,Attachment 2,Supporting & Related Material,Background Material,2026-04-02T04:00:00Z,2026,4,,,2026-04-02T23:42:23Z,,0,0,09000064b924c862
FDA-2026-P-3630-0001,FDA,FDA-2026-P-3630,"Suitability Petition from Rising Pharma Holdings, Inc.",Other,Petition(s),2026-04-02T04:00:00Z,2026,4,2026-04-02T04:00:00Z,,2026-04-28T22:49:43Z,,1,0,09000064b924a278
FDA-2026-P-3630-0002,FDA,FDA-2026-P-3630,"Acknowledgement Letter from FDA DMB to Rising Pharma Holdings, Inc.",Other,Acknowledgement Letter/Receipt,2026-04-02T04:00:00Z,2026,4,2026-04-02T04:00:00Z,,2026-04-02T23:41:50Z,,0,0,09000064b924a279